Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Omega-3 supplements fail to slow cognitive decline in older persons, NIH clinical study shows

While some research suggests that a diet high in omega-3 fatty acids can protect brain health, a large clinical trial by researchers at the National Institutes of Health found that omega-3 supplements did not slow cognitive decline in older persons. With 4,000 patients followed over a five-year period, the study is one of the largest and longest of its kind.

26 Aug 2015

New assessment tool under development can help detect physical traits of Klinefelter syndrome

Klinefelter syndrome is the most common disorder of the male sex chromosomes, yet is rarely diagnosed in children. A new assessment tool is being developed by researchers at Columbia University Medical Center (CUMC) to help pediatricians detect the physical traits of the syndrome. The tool could pave the way for early interventions that prevent and treat a range of physical, psychological, social, and cognitive impairments.

26 Aug 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen today announced that it will present six abstracts at the upcoming ESC Congress 2015, organized by the European Society of Cardiology, being held Aug. 29 – Sept. 2 in London.

26 Aug 2015

Novel ESC paper highlights significance of e-health in tackling heart disease

E-health is vital to winning the battle against heart disease, European cardiology leaders said today in a European Society of Cardiology position paper published in European Heart Journal. The novel paper outlines how the ESC will exploit e-health in education and research, while tackling issues of quality control and data security.

25 Aug 2015

High blood sugar may reduce positive effects of exercise on bone health in diabetic patients

Diabetes, which now affects almost 30 million Americans, can cause serious health complications, including heart disease, blindness, kidney failure and lower-extremity amputations.

24 Aug 2015

High cardiorespiratory fitness levels reduce risk of arrhythmia recurrence in obese atrial fibrillation patients

Obese atrial fibrillation patients have a lower chance of arrhythmia recurrence if they have high levels of cardiorespiratory fitness, and risk continues to decline as exercise capacity increases as part of treatment, according to a study published today in the Journal of the American College of Cardiology.

24 Aug 2015

Primary care physicians' starring role key to weight loss, find Johns Hopkins researchers

A review of survey data from more than 300 obese people who participated in a federally funded weight loss clinical trial found that although the overall weight loss rates were modest, those who rated their primary care doctor's support as particularly helpful lost about twice as many pounds as those who didn't.

24 Aug 2015

Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

Berg, a Boston-based biopharmaceutical company, and the University of Miami Leonard M. Miller School of Medicine are extending its collaboration to battle cardiac dysfunction and heart failure. According to the American Heart Association, cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030.

23 Aug 2015

Potential biomarker could help prevent pre-diabetic individuals from developing Type II diabetes

Virginia Tech researchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes.

21 Aug 2015

Stroke more likely if you work long hours, major study finds

People who work long hours are at a greater risk of stroke and coronary heart disease than people who work a standard week, according to the largest study of the issue to date, published in The Lancet.

20 Aug 2015

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardiance (empagliflozin) in more than 7,000 adults with type 2 diabetes (T2D) at high risk for CV events.

20 Aug 2015

SLUCare cardiac surgeon aims to connect underserved population in St. Louis region with health care services

A new project spearheaded by a Saint Louis University cardiac surgeon is aiming to connect an underserved population with health care services in the St. Louis region.

20 Aug 2015

E-cigarettes becoming more widely available in developing countries

Most of the debate around e-cigarettes has focused on the developed world, but the devices are becoming more widely available in some low- and middle-income countries, where there is even greater potential for impact on public health, say two Stanford University School of Medicine researchers.

19 Aug 2015

Journal articles on yoga therapy increase 3-fold in last 10 years

During the last 10 years, the number of articles in peer-reviewed journals worldwide about clinical trials of yoga therapy to alleviate disease-related symptoms increased 3-fold. This large-scale analysis of published research studies spanning 46 years, 29 countries, and more than 28,000 study participants is published in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

18 Aug 2015

Muscle mass appears to ward off bad cardiovascular effects of obesity

Even without losing fat, more muscle appears to go a long way in fighting off the bad cardiovascular effects of obesity. That emerging evidence has scientists looking hard for new targets to uncouple the unhealthy relationship between fat and cardiovascular disease.

18 Aug 2015

USC kidney researcher named recipient of ASN-AHA Young Investigator Award

Keck School of Medicine of the University of Southern California kidney researcher Janos Peti-Peterdi is the 2015 recipient of the ASN-AHA Young Investigator Award.

14 Aug 2015

ESC Congress to highlight results from global trials in six press conferences

Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research.

13 Aug 2015

New study explains why statins are more beneficial than others in some cases

Statins' success in reducing atherosclerosis-related events has elevated the medications to wonder-drug status, with some researchers advocating for their wider use as a preemptive therapy for cardiovascular disease.

13 Aug 2015

Depressive symptoms, stress, anxiety and anger in RA patients linked to atherosclerosis

New research reveals that depressive symptoms, stress, anxiety, and anger and lack of social support in patients with rheumatoid arthritis (RA) were linked to atherosclerosis--a build-up of fatty deposits in the arteries that contributes to cardiovascular disease. The study published in Arthritis Care & Research, a journal of the American College of Rheumatology, suggests that screening and treatment of psychosocial symptoms may curb the cardiovascular disease burden in RA patients.

13 Aug 2015

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.

12 Aug 2015

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Omega-3 supplements fail to slow cognitive decline in older persons, NIH clinical study shows

New assessment tool under development can help detect physical traits of Klinefelter syndrome

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Novel ESC paper highlights significance of e-health in tackling heart disease

High blood sugar may reduce positive effects of exercise on bone health in diabetic patients

High cardiorespiratory fitness levels reduce risk of arrhythmia recurrence in obese atrial fibrillation patients

Primary care physicians' starring role key to weight loss, find Johns Hopkins researchers

Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

Potential biomarker could help prevent pre-diabetic individuals from developing Type II diabetes

Stroke more likely if you work long hours, major study finds

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

SLUCare cardiac surgeon aims to connect underserved population in St. Louis region with health care services

E-cigarettes becoming more widely available in developing countries

Journal articles on yoga therapy increase 3-fold in last 10 years

Muscle mass appears to ward off bad cardiovascular effects of obesity

USC kidney researcher named recipient of ASN-AHA Young Investigator Award

ESC Congress to highlight results from global trials in six press conferences

New study explains why statins are more beneficial than others in some cases

Depressive symptoms, stress, anxiety and anger in RA patients linked to atherosclerosis

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in